Filter
536
Text search:
nucleic
Acid
Featured
Recommendations
90
New Publications
132
Language
Document type
No document type
249
Guidelines
142
Studies & Reports
69
Manuals
44
Fact sheets
14
Training Material
5
Strategic & Response Plan
5
Situation Updates
4
Infographics
2
Resource Platforms
1
Videos
1
Countries / Regions
India
31
Global
20
Western and Central Europe
17
Eastern Europe
11
South Africa
8
Africa
8
Tanzania
7
Latin America and the Carribbean
7
Liberia
6
Ethiopia
6
Nigeria
5
Nepal
5
Rwanda
5
Brazil
5
Myanmar / Burma
5
Namibia
4
Ukraine
4
Angola
4
East and Southern Africa
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Asia
4
Russia
4
Sierra Leone
3
Congo, Democratic Republic of
3
Germany
3
Zambia
3
Bangladesh
3
Argentina
3
Peru
3
Guinea
2
Senegal
2
Uganda
2
Philippines
2
Pakistan
2
Kenya
2
China
2
Mozambique
2
Middle East and North Africa
2
Vietnam
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Cameroon
1
South Sudan
1
Afghanistan
1
Turkey
1
Syria
1
Chad
1
Cambodia
1
Indonesia
1
Colombia
1
Botswana
1
El Salvador
1
Sri Lanka
1
South–East Asia Region
1
Bhutan
1
Timor Leste/ East Timor
1
Moldova
1
Georgia
1
France
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
114
Clinical Guidelines
96
Pharmacy & Technologies
33
Key Resources
14
Women & Child Health
13
Public Health
12
Capacity Building
3
Toolboxes
TB
105
COVID-19
86
HIV
71
NTDs
42
Ebola & Marburg
23
Rapid Response
22
Zika
17
AMR
12
Refugee
11
Pharmacy
11
2.0 Rapid Response
11
Malaria
8
Polio
5
Planetary Health
4
Caregiver
3
Conflict
2
Mental Health
2
Health Financing Toolbox
2
Natural Hazards
1
Specific Hazards
1
Global Health Education
1
NCDs
1
WHO Technical Series 971
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C
...
23rd February 2017, Protea Hotel Thuringerhof, Windhoek | 2017 Namibia ART Guidelines: Summary of New and Old Recommendations
Copenhagen, Denmark, 24–25 August 2017
A survival guide for clinicans.
3rd edition.
(actualizado en diciembre de 2014).
Diagnostics 2019, 9(4), 204; https://doi.org/10.3390/diagnostics9040204
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti
...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat
...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti
...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri
...